Simplex Trading, LLC Immunity Bio, Inc. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$1.25 - $5.21 $54,288 - $226,275	43,431 Added 488.92%	52,314 $262,000
Q3 2023 Nov 01, 2023	BUY	$1.29 - $3.1 $11,459 - $27,537	8,883 New	8,883 $15,000
Q1 2023 Apr 27, 2023	BUY	$1.35 - $4.78 $145,497 - $515,169	107,776 Added 5415.88%	109,766 $199,000
Q4 2022 Feb 02, 2023	SELL	$4.35 - $6.77 $231,689 - $360,583	-53,262 Reduced 96.4%	1,990 $10,000
Q3 2022 Nov 04, 2022	BUY	$3.65 - $6.43 $52,560 - $92,592	14,400 Added 35.25%	55,252 $274,000
Q2 2022 Aug 03, 2022	BUY	$2.68 - $6.14 $44,798 - $102,636	16,716 Added 69.26%	40,852 $151,000
Q1 2022 May 02, 2022	SELL	$5.05 - $7.53 $284,375 - $424,029	-56,312 Reduced 70.0%	24,136 $135,000
Q4 2021 Feb 23, 2022	BUY	$5.67 - $10.18 $437,202 - $784,959	77,108 Added 2308.62%	80,448 $489,000
Q3 2021 Oct 28, 2021	BUY	$9.17 - $14.24 $4,117 - $6,393	449 Added 15.53%	3,340 $47,000
Q2 2021 Aug 12, 2021	SELL	$13.41 - $22.4 $490,390 - $819,145	-36,569 Reduced 92.67%	2,891 $41,000
Q1 2021 Apr 26, 2021	BUY	$12.83 - $42.25 $506,271 - $1.67 Million	39,460 New	39,460 $936,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.